Effective Natural Remedies for Glaucoma Management

Citicoline
Posted by Lin (New Mexico) on 02/07/2024
★★★★★

On my third capsule of CDP Citicoline (250mg/dose) and I feel like a new person. The first dose totally relieved eye pressure within an hour. I also researched into heat shock proteins and I feel there is finally some hope for a realistic cure. As it also protects against Alzheimers (over 70 here) I feel its an amazing win. Thank you for posting this.


Citicoline
Posted by Art (California) on 03/29/2022 2147 posts
★★★★★

There are now multiple studies (RCTs) showing that Citicoline is effective for relieving Glaucoma.

Here is a new study( March 2022) showing the efficacy of Citicoline at just 250 mg/day for Glaucoma :

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907038/

Here is a relevant quote from the study :

>>> ' With oral citicoline treatment, the loss in the average RNFL is prevented in POAG patients in the short-term. Study data show that citicoline may have a significant impact on slowing glaucoma progression, which could have a potential neuroprotective effect.'<<<

In the following RCT (June 2020) it is shown that even eye drops utilizing Citicoline is effective for Glaucoma :

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337116/

Here is a relevant quote from the study :

>>> ' Additional treatment with citicoline eyedrops to IOP-lowering treatment might reduce disease progression in patients with progressing glaucoma despite IOP ≤18 mm Hg. ' <<<

In this last comprehensive review (March 2021) the protective role of Citicoline against the effects of glaucoma related neurodegeneration are elucidated in greater detail :

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003774/

Here is a relevant quote from the study :

>>> ' In addition to the evidences of an improvement of psychophysical, morphological, and electrophysiological outcomes, coming from small comparative randomized pilot clinical trials or larger not controlled before-after studies (performed in different ophthalmological neurodegenerative diseases, like OAG, AION, and DR), for the first time a reduction of the rate of visual field progression has been recently reported in OAG patients in a large randomized double-masked placebo-controlled clinical trial, thus further supporting the clinical use of citicoline. ' <<<

:::::::::::::::::::::::::::::::::::::

Art



Advertisement